Pharma & Biotech VC & Investment News
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Today's issue
Refine Search
Pharmaceutical
Netherlands-incorporated Mylan and Mapi Pharma, a fully integrated, clinical late stage biopharmaceutical company, today announced that the two companies will partner on the development and commercialization of GA Depot, a long-acting glatiramer acetate product. 10 April 2018
Biotechnology
Whether positive or negative, the findings from reports on elements of the UK economy are frequently linked to UK’s imminent exit from the European Union in the current Brexit-obsessed media environment. 10 April 2018
Biotechnology
Belgian cell therapy company Promethera Biosciences has acquired Baliopharm, a Swiss biopharmaceutical company focused on the development of targeted biological therapies for immune mediated inflammatory diseases and cancer. 10 April 2018
Biotechnology
A new biotech startup founded by stem cell specialists from Harvard has won backing from Amgen Ventures, Alexandria Venture Investments and the investment arm of Mitsubishi Tanabe in its goal to find a cure for amyotrophic lateral sclerosis (ALS). 6 April 2018
Biotechnology
The Chinese authority is drafting a system for pharmaceutical patent linkage and drug patent term extension, both are expected to be introduced in 2018, said Song Ruilin, executive president of PhIRDA, a state-backed organization that lobbies for Chinese pharma companies, at the China Healthcare Investment Conference (CHIC) held from March 27 to 29 in Shanghai, reports Wang Fangqing, The Pharma Letter’s local correspondent. 4 April 2018
Biotechnology
A start-up has in-licensed the allogeneic CAR-T portfolio of the world’s largest pharma company in a deal that grabbed the attention of the drugmaking world on Tuesday. 3 April 2018
Pharmaceutical
The CARB-X accelerator, a project devoted to early stage antibacterial R&D, is to partner with Osaka-based Shionogi. 22 March 2018
Biotechnology
TCR2 Therapeutics, an immuno-oncology (I-O) company claiming to be developing a new class of T cell receptor (TCR)-based cellular therapies for both solid tumors and blood cancers, has completed an oversubscribed Series B financing of $125 million. 22 March 2018
Pharmaceutical
Although there have been some new drugs approved for the treatment of Duchenne muscular dystrophy (DMD) in the past year or two, none are seen as being particularly effective therapy. 21 March 2018
Biotechnology
In a second European cancer financing deal this year, Canada’s Portage Biotech (OTC: PTGEF) says that it has made an investment in iOx Therapeutics, UK-based immuno-oncology company. 8 March 2018
Biotechnology
A new partnership between Austrian biotech Themis Bioscience and Oslo-based CEPI – the Coalition for Epidemic Preparedness Innovations – will see an investment of up to $37.5 million going into vaccine development and manufacturing for Lassa fever and MERS. 8 March 2018
Biotechnology
US biotech Rubius Therapeutics, which calls itself the world’s only company developing natural blood that has been made therapeutically active, has completed an oversubscribed $100 million crossover financing, adding to the $120 million that it raised nine months ago. 1 March 2018
Pharmaceutical
Boston, USA-based Gelesis has raised $30 million to support development of its pipeline of gastrointestinal disorder therapies, which includes candidates targeting type 2 diabetes and non-alcoholic steatohepatitis (NASH). 1 March 2018
Biotechnology
The biologics arm of UK-based AstraZeneca is putting six molecules from its early-stage inflammation and autoimmunity programs at the heart of a newly formed company, called Viela Bio. 28 February 2018
Biotechnology
ORIC Pharmaceuticals, a US clinical-stage oncology company focused on discovery and development of novel therapies against treatment-resistant cancers, has completed a $50 million Series C preferred stock financing. 21 February 2018
Pharmaceutical
Merck KGaA today announced the creation of ExploreBio, a pre-seed-investment vehicle by four investment funds targeted at early-stage companies in the biotechnology landscape in Israel. 20 February 2018
Pharmaceutical
A new firm dubbed Gain Therapeutics has been spun out of Barcelona’s Minoryx Therapeutics, centered around the SEE-Tx platform to develop treatments for rare metabolic diseases. 20 February 2018
Biotechnology
Polish biotech firm Selvita pleased investors with its announcement of a major share 2.2 million placement, sending its shares 4.68% higher to 64.80 zlotys 19 February 2018
Pharmaceutical
Spain-based ABAC Therapeutics, a leader in pathogen-specific antibiotics, announced today the closing of a 16 million euros (~$20 million) Series A round. 15 February 2018
Biotechnology
US biotech startup Moderna Therapeutics, a company specializing in messenger RNA (mRNA), has raised $500 million in a fundraising that values the firm at more than $7 billion. 2 February 2018
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
Shanghai-based Leading Tac Pharmaceutical has announced the successful completion of a series A financing round, raising over 100 million yuan ($14 million). 21 November 2024
Biotechnology
A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry promised to build bold, science-driven therapeutics companies. 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Californian oncology-focused biotech Avenzo Therapeutics has announced a pair of important updates. 19 November 2024
Pharmaceutical
In yet another sign of the mounting interest in radiopharmaceuticals, Tongrui Biopharma, a Chinese innovator in this area, has announced the completion of a $100 million series A+ financing round. 18 November 2024
Biotechnology
Shanghai-based biopharma Zai Lab has announced the pricing of its underwritten public offering at $25.50 per share, aiming to raise around $200 million. 15 November 2024
Pharmaceutical
New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series B financing to further advance its portfolio of clinical-stage, nutrient-stimulated hormone (NuSH) analog peptides. 14 November 2024
Pharmaceutical
Life science investor Syncona has announced the launch of its newest portfolio company, Slingshot Therapeutics, through the Syncona Accelerator initiative. 14 November 2024
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Biotechnology
Trace Neuroscience, a newly launched biopharma based in San Francisco, aims to advance treatments for neurodegenerative diseases, starting with amyotrophic lateral sclerosis (ALS). 12 November 2024
Biotechnology
Geron Corporation, a biopharma company focused on telomerase inhibition therapies, has announced a $375 million financing agreement aimed at supporting the commercial rollout of Rytelo (imetelstat). 11 November 2024
Biotechnology
An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug R&D. 11 November 2024
Biotechnology
US biotech venture fund Aditum Bio and China’s Leads Biolabs today announced the formation of Oblenio Bio, marking the thirteenth company launched by Aditum. 7 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze